🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized study evaluates the effect of subcutaneous semaglutide /in ...
Status
Terminated
Location
Geisinger Medical Center
Start Date
2021-07-23
Trial ID
NCT04741074
Peripheral arterial disease (PAD) is a manifestation of systemic atheroscle...
Status
Unknown
Location
University of Southern California
Start Date
2017-12-14
Trial ID
NCT04306081
The incidence of Type 2 Diabetes Mellitus (T2DM) is increasing day by day b...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2017-08-14
Trial ID
NCT03015519
Treatments Being Tested
This study is designed to examine the efficacy and safety of 2 dose levels ...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-02
Trial ID
NCT01733758
Treatments Being Tested
The purpose of this research study is to see the effect of the diabetes med...
Status
Completed
Location
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center
Start Date
2019-04-30
Trial ID
NCT03985384
Treatments Being Tested
This is a phase III, randomized, double-blind, multicenter, parallel group,...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-16
Trial ID
NCT02683746
This is a prospective randomized, double-blinded, placebo-controlled, phase...
Status
Completed
Location
Hospital for Special Surgery
Start Date
2020-09-17
Trial ID
NCT04249232
Treatments Being Tested
This is a Phase II, randomized, double-blind, parallel group, placebo contr...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-10-10
Trial ID
NCT02284009
Treatments Being Tested
Albiglutide (Alb) is a novel analogue of glucagon-like peptide-1 (GLP-1) ha...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-02
Trial ID
NCT02660736
This clinical study examines whether tirzepatide can improve ovarian dysfun...
Status
Recruiting
Location
University Hospital BG Bergmannsheil Bochum General internal medicine, endocrinology and diabetology, gastroenterology and hepatology
Start Date
2025-12-09
Trial ID
NCT07326111